LTFS
ABMD

Ladenburg Thalmann Financial Services’s Abiomed Inc ABMD Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$400K Sell
2,352
-313
-12% -$58K ﹤0.01% 2004
2019
Q3 		$474K Buy
2,665
+1,726
+184% +$373K ﹤0.01% 1815
2019
Q2 		$245K Sell
939
-537
-36% -$142K ﹤0.01% 2324
2019
Q1 		$421K Sell
1,476
-2,361
-62% -$785K ﹤0.01% 1827
2018
Q4 		$1.25M Buy
3,837
+1,108
+41% +$385K 0.01% 910
2018
Q3 		$1.23M Buy
2,729
+377
+16% +$149K 0.01% 1002
2018
Q2 		$682K Hold
2,352
– – 0.01% 1320
2018
Q1 		$682K Buy
2,352
+787
+50% +$199K 0.01% 1320
2017
Q4 		$294K Buy
1,565
+64
+4% +$11.9K ﹤0.01% 1911
2017
Q3 		$253K Sell
1,501
-76
-5% -$11.5K ﹤0.01% 1924
2017
Q2 		$226K Sell
1,577
-1
-0.1% -$134 ﹤0.01% 1922
2017
Q1 		$198K Sell
1,578
-9,805
-86% -$1.14M ﹤0.01% 1920
2016
Q4 		$1.28M Sell
11,383
-2,330
-17% -$270K 0.02% 721
2016
Q3 		$1.76M Buy
13,713
+1,649
+14% +$198K 0.03% 539
2016
Q2 		$1.32M Sell
12,064
-763
-6% -$75.9K 0.02% 632
2016
Q1 		$1.22M Sell
12,827
-228
-2% -$19.2K 0.02% 609
2015
Q4 		$1.18M Buy
13,055
+11,000
+535% +$934K 0.02% 611
2015
Q3 		$191K Buy
2,055
+1,130
+122% +$99.6K ﹤0.01% 1517
2015
Q2 		$61K Sell
925
-1,425
-61% -$94.7K ﹤0.01% 2451
2015
Q1 		$168K Buy
2,350
+1,750
+292% +$95K ﹤0.01% 1700
2014
Q4 		$23K Buy
600
+100
+20% +$3.15K ﹤0.01% 2907
2014
Q3 		$12K Hold
500
– – ﹤0.01% 3004
2014
Q2 		$13K Hold
500
– – ﹤0.01% 2953
2014
Q1 		$13K Hold
500
– – ﹤0.01% 2828
2013
Q4 		$13K Sell
500
-200
-29% -$4.94K ﹤0.01% 2790
2013
Q3 		$13K Buy
700
+500
+250% +$11.4K ﹤0.01% 2720
2013
Q2 		$4K Buy
+200
New +$4.02K ﹤0.01% 3163

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ABMD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Abiomed Inc (ABMD) stake by 12% in Q4 2019, selling an estimated $58K and leaving 2,352 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Ladenburg Thalmann Financial Services first reported a position in ABMD in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.76M in Q3 2016. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 2,352 shares of Abiomed Inc worth $400K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 313 Abiomed Inc shares in Q4 2019, an estimated $58K.
  • Abiomed Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2004 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Abiomed Inc in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Abiomed Inc position peaked at $1.76M in Q3 2016.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.